Experts want healthcare providers to wean patients from sleep medications when they are no longer needed and switch to CBT-I.
The failures of ZEUS, HORIZON, and CorCal; numerous papers from the JACC special issue on LAAC; and the COAST-AF trial in ...
The long-acting injectable growth hormone somapacitan-beco is also approved for other growth deficiencies in adults and children.
In endometrial cancer that has outlasted platinum chemotherapy and immunotherapy, a novel antibody–drug conjugate was pitted against doxorubicin or weekly paclitaxel.
Up to 1 in 5 children with chronic conditions have a mental health diagnosis, with digestive system, cardiovascular, and ...
A novel ASM significantly reduced focal seizures within the first week of treatment, with sustained benefit over 12 weeks in ...
A phase 1/2 trial explores dose and infusion schedule optimization of a propylene glycol-free melphalan formulation in patients with newly diagnosed myeloma undergoing autologous stem cell transplant.
A nurse-led, app-supported program is linked to modest improvements in estimated dementia risk profiles among middle-aged ...
Physicians most often trace misinformation/disinformation to social media and influencers, but when it comes via word of ...
Patients with type 2 diabetes who discontinue GLP-1 receptor agonists face about double the risk of experiencing heart attack ...
Oncologists and radiologists are holding out hope that Congress will reverse physician fee cuts before the end of the year.
NETTER-2 found longer progression-free survival with first-line PRRT, but experts differ on which patients should receive it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results